Business Context and Reporting Period
This Form 6-K filing by Evogene Ltd. covers the month of April 2022, with the report dated April 26, 2022. The filing serves as a report of a foreign private issuer and incorporates by reference an exhibit titled "AgPlenus Investor Presentation."
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a cover sheet for an attached investor presentation rather than a financial statement.
Material Changes
The filing text does not provide data to compare against prior periods or identify material financial changes.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, risks, contingencies, and unusual items are not detailed in the provided text. The filing references an attached presentation (Exhibit 99.1) which likely contains this information, but the content of that exhibit is not included in the source text.
Key Facts for Investor Verification
- The filing is a Form 6-K dated April 26, 2022, signed by Yaron Eldad, Chief Financial Officer.
- The primary content is an attached "AgPlenus Investor Presentation" (Exhibit 99.1), the details of which are not present in the filing text.
- No financial figures or operational metrics are disclosed within the provided text.